Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,954,537
-
Share change
-
-300,196
-
Total reported value
-
$68,503,621
-
Price per share
-
$9.85
-
Number of holders
-
37
-
Value change
-
-$6,760,931
-
Number of buys
-
24
-
Number of sells
-
16
Institutional Holders of EIGER BIOPHARMACEUTICALS INC - COM (EIGR) as of Q1 2018
As of 31 Mar 2018,
EIGER BIOPHARMACEUTICALS INC - COM (EIGR) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,954,537 shares.
The largest 10 holders included
Vivo Capital, LLC, INTERWEST VENTURE MANAGEMENT CO, JENNISON ASSOCIATES LLC, Prosight Management, LP, SPHERA FUNDS MANAGEMENT LTD., VANGUARD GROUP INC, 683 Capital Management, LLC, HIGHBRIDGE CAPITAL MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, and PERCEPTIVE ADVISORS LLC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.